Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
NCT04314999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57
Last updated 2020-03-19
Summary
The goal of this study is to describe the prevalence and the type of parasite in patients with a chronic spontaneous urticaria as well as to describe the associations between parasitic disease and the characteristics of the patients, for example eosinophilia.
Conditions
- Chronic Spontaneous Urticaria
- Parasitic Disease
Interventions
- DIAGNOSTIC_TEST
-
Examination of stool samples
Tests for diagnosis of parasitic diseases
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Esther Steveling-Klein, Dr. med. · Allergology, University Hospital Basel
Eligibility
- Min Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-01
- Primary Completion
- 2019-09-30
- Completion
- 2019-09-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Tranexamic Acid and Spontaneous Chronic Urticaria
NCT03789422 ·Status: UNKNOWN ·Phase: PHASE4
-
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
NCT06927999 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of AK002 in Subjects With Antihistamine-Resistant Chronic Urticaria
NCT03436797 ·Status: COMPLETED ·Phase: PHASE2
-
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis
NCT04915352 ·Status: TERMINATED ·Phase: PHASE4
-
Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency
NCT02565680 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria
NCT05335499 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria
NCT00525382 ·Status: COMPLETED ·Phase: PHASE3
-
Chronic Urticaria - Long Term Assessment of Effects of Rupatadine
NCT02358265 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)
NCT00598611 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients
NCT02399579 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria
NCT02372604 ·Status: COMPLETED ·Phase: PHASE3
-
Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
NCT05334940 ·Status: RECRUITING
-
Detection of Viral Particels in Urticaria Patients
NCT03151902 ·Status: COMPLETED
-
Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites
NCT01485523 ·Status: COMPLETED
-
Local IgE in Subjects With Allergic or Non-allergic Rhinitis
NCT02810535 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
NCT06072157 ·Status: COMPLETED ·Phase: PHASE1
-
Management of Drug Hypersensitivity in Children
NCT02031120 ·Status: TERMINATED
-
A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).
NCT03137069 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites
NCT00521131 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001
NCT06577116 ·Status: COMPLETED ·Phase: PHASE1
-
Determinism of the Mechanism of Action of Specific Immunotherapy in Hymenoptera Venom Allergy
NCT02295488 ·Status: COMPLETED ·Phase: NA
-
Clinical and Immunological Evaluation of Children With Allergies
NCT00102570 ·Status: COMPLETED
-
Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis
NCT00461721 ·Status: COMPLETED
-
Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria
NCT00481676 ·Status: COMPLETED ·Phase: PHASE2
-
Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
NCT00232518 ·Status: COMPLETED ·Phase: NA